Market Outlook
The global Dengue Vaccines market size was valued at USD 412.2 million in 2022 and is forecast to a readjusted size of USD 1010.9 million by 2029 with a CAGR of 13.7% during review period.
Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.
The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't have enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.
This report is a detailed and comprehensive analysis for global Dengue Vaccines market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Dengue Vaccines market size and forecasts, in consumption value ($ Million), 2018-2029
Global Dengue Vaccines market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Dengue Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Dengue Vaccines market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dengue Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dengue Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Sanofi
Takeda
Segmentation By Type
Dengvaxia
TAK-003
Others
Segmentation By Application
Public Sector
Private Sector
Segmentation By Region
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Dengue Vaccines Market in 2025?
The strength of the Dengue Vaccines Market in 2025 lies in increasing awareness about the disease, growing public health initiatives, and advancements in vaccine development, particularly with newer, more effective vaccines entering the market.
What are the weaknesses of the Dengue Vaccines Market in 2025?
Weaknesses include limited access to vaccines in low-income regions, high costs associated with vaccine production and distribution, and challenges related to public acceptance and awareness in some areas.
What are the opportunities for the Dengue Vaccines Market in 2025?
Opportunities include expanding the market in endemic areas, collaborations between governments, NGOs, and private sector companies, and the potential for new vaccine formulations that offer longer-lasting protection or are easier to administer.
What are the threats to the Dengue Vaccines Market in 2025?
Threats include the emergence of new variants of the virus that may evade current vaccines, logistical challenges in vaccine distribution to remote areas, and political or economic instability that could delay or disrupt vaccination efforts.
Market PESTEL Analysis
What are the political factors affecting the Dengue Vaccines Market in 2025?
Political factors include government support for public health initiatives, the formulation of policies to address dengue outbreaks, and the role of international organizations in providing funding and resources for vaccine distribution in endemic regions.
What are the economic factors influencing the Dengue Vaccines Market in 2025?
Economic factors include the affordability of vaccines in developing nations, investment in research and development, and the financial capabilities of governments and organizations to fund vaccination campaigns. The cost of production and distribution also plays a key role in determining market accessibility.
What are the social factors affecting the Dengue Vaccines Market in 2025?
Social factors involve increasing awareness about dengue and the importance of vaccination, cultural perceptions toward vaccines, and public trust in new vaccine technologies. Public education campaigns can significantly impact vaccine uptake.
What are the technological factors influencing the Dengue Vaccines Market in 2025?
Technological factors include advancements in vaccine development, improvements in vaccine delivery methods, and the ability to produce vaccines more efficiently. Emerging technologies such as mRNA vaccine platforms may play a significant role in the market's growth.
What are the environmental factors affecting the Dengue Vaccines Market in 2025?
Environmental factors include the spread of dengue due to climate change, as warmer temperatures and rainfall patterns can increase the population of mosquitoes carrying the virus. This affects vaccine demand and distribution strategies, particularly in affected regions.
What are the legal factors influencing the Dengue Vaccines Market in 2025?
Legal factors include regulatory approvals for new vaccines, intellectual property laws that may affect vaccine availability, and liability concerns surrounding vaccine safety and adverse effects. Governments must navigate these legal frameworks to ensure timely and widespread vaccine access.
Market SIPOC Analysis
Who are the suppliers in the Dengue Vaccines Market in 2025?
Suppliers in the Dengue Vaccines Market include pharmaceutical companies developing the vaccines, raw material providers for vaccine production, and research institutions supporting clinical trials and scientific advancements.
What are the inputs in the Dengue Vaccines Market in 2025?
Inputs include research and development resources, raw materials for vaccine production (like antigens, stabilizers), skilled labor, regulatory approvals, and financial investments to support vaccine manufacturing and distribution.
What is the process involved in the Dengue Vaccines Market in 2025?
The process involves research and development of vaccines, clinical testing, regulatory approvals, large-scale manufacturing, distribution to health organizations, and implementation of vaccination campaigns in endemic areas.
Who are the customers in the Dengue Vaccines Market in 2025?
Customers include governments and health organizations in endemic regions, healthcare providers, NGOs, and the general population in areas at high risk of dengue outbreaks.
What are the outputs in the Dengue Vaccines Market in 2025?
The outputs include the developed and approved dengue vaccines, distribution networks to deliver vaccines, vaccination campaigns, and data on vaccine effectiveness and safety.
Market Porter's Five Forces
How strong is the threat of new entrants in the Dengue Vaccines Market in 2025?
The threat of new entrants is moderate due to the high capital investment and regulatory hurdles required to develop and approve vaccines. Established pharmaceutical companies with resources and expertise dominate the market, making it challenging for new players to enter.
How intense is the bargaining power of suppliers in the Dengue Vaccines Market in 2025?
The bargaining power of suppliers is moderate. While raw materials for vaccine production are critical, multiple suppliers exist, and vaccine manufacturers can often negotiate terms. However, specialized ingredients or proprietary technology may give some suppliers higher power.
How high is the bargaining power of buyers in the Dengue Vaccines Market in 2025?
The bargaining power of buyers is moderate to high. Governments and health organizations, being large-scale buyers, can negotiate for lower prices, especially for mass vaccination programs. However, the essential nature of the vaccine for public health limits the extent of this power.
How high is the threat of substitute products in the Dengue Vaccines Market in 2025?
The threat of substitutes is low. There are currently no direct substitutes for dengue vaccines, as they provide specific immunity to the disease. Preventative measures like mosquito control remain alternatives but do not fully replace vaccination.
How competitive is the rivalry among existing players in the Dengue Vaccines Market in 2025?
The rivalry among existing players is moderate. While the market is dominated by a few large pharmaceutical companies, there is still room for competition as companies innovate with new formulations and improve accessibility. However, the niche nature of the market reduces overall competition.
Market Upstream Analysis
What are the key inputs in the Dengue Vaccines Market in 2025?
Key inputs include raw materials for vaccine production (such as antigens, stabilizers, and preservatives), research and development resources, and regulatory approval processes. Skilled labor, technology for vaccine production, and funding for clinical trials are also essential.
Who are the suppliers in the Dengue Vaccines Market in 2025?
Suppliers include pharmaceutical companies that develop the vaccines, raw material suppliers for vaccine production, research institutions providing scientific knowledge and innovation, and contract manufacturers involved in vaccine production and packaging.
What are the production capabilities in the Dengue Vaccines Market in 2025?
Production capabilities are primarily driven by large-scale pharmaceutical companies with the infrastructure to manufacture vaccines at high volumes. Companies with specialized expertise in vaccine production technology and regulatory compliance have a competitive edge in scaling production.
What is the role of research and development in the Dengue Vaccines Market in 2025?
R&D plays a critical role in the development of new, more effective dengue vaccines, improving vaccine efficacy, and addressing emerging virus strains. Ongoing innovation in vaccine technology, such as mRNA platforms, also contributes to advancing production capabilities and market offerings.
What are the challenges faced by upstream players in the Dengue Vaccines Market in 2025?
Challenges include high R&D costs, long development timelines, regulatory hurdles, and the need to ensure a consistent and reliable supply of raw materials. Manufacturers must also address potential supply chain disruptions and ensure vaccines meet stringent safety and efficacy standards.
Market Midstream Analysis
What are the key activities in the midstream of the Dengue Vaccines Market in 2025?
Key activities in the midstream include vaccine manufacturing, quality control, packaging, and distribution. This phase also involves collaboration with health organizations and governments to ensure efficient vaccine delivery to target regions.
What role do distribution channels play in the Dengue Vaccines Market in 2025?
Distribution channels are critical to ensure that vaccines reach endemic regions efficiently. These channels include government procurement, partnerships with healthcare providers, NGOs, and direct distribution to vaccination centers in affected areas.
What are the challenges faced in the midstream of the Dengue Vaccines Market in 2025?
Challenges include ensuring the cold chain for vaccine storage and transportation, managing logistical complexities in remote areas, and meeting the high demand during peak seasons. Delays in distribution and stockouts can significantly impact vaccination efforts.
How does regulatory compliance affect the midstream of the Dengue Vaccines Market in 2025?
Regulatory compliance is essential at this stage to ensure vaccines meet safety, efficacy, and quality standards. Adherence to local regulations and international standards helps avoid delays in vaccine availability and ensures the trustworthiness of the product in the market.
What are the partnerships and collaborations in the midstream of the Dengue Vaccines Market in 2025?
Partnerships between vaccine manufacturers, governments, international health organizations, and non-profit groups are key in financing, distributing, and implementing vaccination programs. These collaborations also help improve access in low-resource settings and ensure widespread coverage.
Market Downstream Analysis
What are the key activities in the downstream of the Dengue Vaccines Market in 2025?
Key activities in the downstream include the administration of vaccines to the public, monitoring vaccine effectiveness, post-vaccination surveillance, and addressing any adverse effects. This stage also involves educating the public and ensuring access to vaccines in affected regions.
What role do healthcare providers play in the downstream of the Dengue Vaccines Market in 2025?
Healthcare providers, including doctors, nurses, and vaccination centers, are crucial in administering the vaccine, managing patient care, and reporting outcomes. They also play a key role in raising awareness about the importance of vaccination.
What are the challenges in the downstream of the Dengue Vaccines Market in 2025?
Challenges include overcoming vaccine hesitancy, ensuring equitable access in underserved areas, and addressing logistical issues such as vaccine delivery in remote regions. Additionally, there may be challenges related to monitoring and reporting adverse reactions in large-scale vaccination programs.
How does public awareness impact the downstream of the Dengue Vaccines Market in 2025?
Public awareness is crucial in ensuring high vaccine uptake. Effective communication campaigns are needed to inform communities about the importance of vaccination, the risks of dengue, and the availability of vaccines, which can drive demand and participation in vaccination programs.
What are the key outcomes expected from the downstream activities in the Dengue Vaccines Market in 2025?
Key outcomes include widespread vaccination coverage, a reduction in dengue incidence, improved public health, and long-term herd immunity. Effective downstream activities will also result in better control of dengue outbreaks and lower healthcare costs associated with treating the disease.
Chapter 1, to describe Dengue Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Dengue Vaccines, with revenue, gross margin and global market share of Dengue Vaccines from 2018 to 2023.
Chapter 3, the Dengue Vaccines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Dengue Vaccines market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Dengue Vaccines.
Chapter 13, to describe Dengue Vaccines research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Dengue Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Dengue Vaccines by Type
1.3.1 Overview: Global Dengue Vaccines Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Dengue Vaccines Consumption Value Market Share by Type in 2022
1.3.3 Dengvaxia
1.3.4 TAK-003
1.3.5 Others
1.4 Global Dengue Vaccines Market by Application
1.4.1 Overview: Global Dengue Vaccines Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Public Sector
1.4.3 Private Sector
1.5 Global Dengue Vaccines Market Size & Forecast
1.6 Global Dengue Vaccines Market Size and Forecast by Region
1.6.1 Global Dengue Vaccines Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Dengue Vaccines Market Size by Region, (2018-2029)
1.6.3 North America Dengue Vaccines Market Size and Prospect (2018-2029)
1.6.4 Europe Dengue Vaccines Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Dengue Vaccines Market Size and Prospect (2018-2029)
1.6.6 South America Dengue Vaccines Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Dengue Vaccines Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Dengue Vaccines Product and Solutions
2.1.4 Sanofi Dengue Vaccines Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Dengue Vaccines Product and Solutions
2.2.4 Takeda Dengue Vaccines Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Takeda Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Dengue Vaccines Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Dengue Vaccines by Company Revenue
3.2.2 Top 3 Dengue Vaccines Players Market Share in 2022
3.2.3 Top 6 Dengue Vaccines Players Market Share in 2022
3.3 Dengue Vaccines Market: Overall Company Footprint Analysis
3.3.1 Dengue Vaccines Market: Region Footprint
3.3.2 Dengue Vaccines Market: Company Product Type Footprint
3.3.3 Dengue Vaccines Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Dengue Vaccines Consumption Value and Market Share by Type (2018-2023)
4.2 Global Dengue Vaccines Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Dengue Vaccines Consumption Value Market Share by Application (2018-2023)
5.2 Global Dengue Vaccines Market Forecast by Application (2024-2029)
6 North America
6.1 North America Dengue Vaccines Consumption Value by Type (2018-2029)
6.2 North America Dengue Vaccines Consumption Value by Application (2018-2029)
6.3 North America Dengue Vaccines Market Size by Country
6.3.1 North America Dengue Vaccines Consumption Value by Country (2018-2029)
6.3.2 United States Dengue Vaccines Market Size and Forecast (2018-2029)
6.3.3 Canada Dengue Vaccines Market Size and Forecast (2018-2029)
6.3.4 Mexico Dengue Vaccines Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Dengue Vaccines Consumption Value by Type (2018-2029)
7.2 Europe Dengue Vaccines Consumption Value by Application (2018-2029)
7.3 Europe Dengue Vaccines Market Size by Country
7.3.1 Europe Dengue Vaccines Consumption Value by Country (2018-2029)
7.3.2 Germany Dengue Vaccines Market Size and Forecast (2018-2029)
7.3.3 France Dengue Vaccines Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Dengue Vaccines Market Size and Forecast (2018-2029)
7.3.5 Russia Dengue Vaccines Market Size and Forecast (2018-2029)
7.3.6 Italy Dengue Vaccines Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Dengue Vaccines Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Dengue Vaccines Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Dengue Vaccines Market Size by Region
8.3.1 Asia-Pacific Dengue Vaccines Consumption Value by Region (2018-2029)
8.3.2 China Dengue Vaccines Market Size and Forecast (2018-2029)
8.3.3 Japan Dengue Vaccines Market Size and Forecast (2018-2029)
8.3.4 South Korea Dengue Vaccines Market Size and Forecast (2018-2029)
8.3.5 India Dengue Vaccines Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Dengue Vaccines Market Size and Forecast (2018-2029)
8.3.7 Australia Dengue Vaccines Market Size and Forecast (2018-2029)
9 South America
9.1 South America Dengue Vaccines Consumption Value by Type (2018-2029)
9.2 South America Dengue Vaccines Consumption Value by Application (2018-2029)
9.3 South America Dengue Vaccines Market Size by Country
9.3.1 South America Dengue Vaccines Consumption Value by Country (2018-2029)
9.3.2 Brazil Dengue Vaccines Market Size and Forecast (2018-2029)
9.3.3 Argentina Dengue Vaccines Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Dengue Vaccines Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Dengue Vaccines Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Dengue Vaccines Market Size by Country
10.3.1 Middle East & Africa Dengue Vaccines Consumption Value by Country (2018-2029)
10.3.2 Turkey Dengue Vaccines Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Dengue Vaccines Market Size and Forecast (2018-2029)
10.3.4 UAE Dengue Vaccines Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Dengue Vaccines Market Drivers
11.2 Dengue Vaccines Market Restraints
11.3 Dengue Vaccines Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Dengue Vaccines Industry Chain
12.2 Dengue Vaccines Upstream Analysis
12.3 Dengue Vaccines Midstream Analysis
12.4 Dengue Vaccines Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Dengue Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Dengue Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Dengue Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Dengue Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Sanofi Company Information, Head Office, and Major Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi Dengue Vaccines Product and Solutions
Table 8. Sanofi Dengue Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Sanofi Recent Developments and Future Plans
Table 10. Takeda Company Information, Head Office, and Major Competitors
Table 11. Takeda Major Business
Table 12. Takeda Dengue Vaccines Product and Solutions
Table 13. Takeda Dengue Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Takeda Recent Developments and Future Plans
Table 15. Global Dengue Vaccines Revenue (USD Million) by Players (2018-2023)
Table 16. Global Dengue Vaccines Revenue Share by Players (2018-2023)
Table 17. Breakdown of Dengue Vaccines by Company Type (Tier 1, Tier 2, and Tier 3)
Table 18. Market Position of Players in Dengue Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 19. Head Office of Key Dengue Vaccines Players
Table 20. Dengue Vaccines Market: Company Product Type Footprint
Table 21. Dengue Vaccines Market: Company Product Application Footprint
Table 22. Dengue Vaccines New Market Entrants and Barriers to Market Entry
Table 23. Dengue Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 24. Global Dengue Vaccines Consumption Value (USD Million) by Type (2018-2023)
Table 25. Global Dengue Vaccines Consumption Value Share by Type (2018-2023)
Table 26. Global Dengue Vaccines Consumption Value Forecast by Type (2024-2029)
Table 27. Global Dengue Vaccines Consumption Value by Application (2018-2023)
Table 28. Global Dengue Vaccines Consumption Value Forecast by Application (2024-2029)
Table 29. North America Dengue Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 30. North America Dengue Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 31. North America Dengue Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 32. North America Dengue Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 33. North America Dengue Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 34. North America Dengue Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 35. Europe Dengue Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 36. Europe Dengue Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 37. Europe Dengue Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 38. Europe Dengue Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 39. Europe Dengue Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 40. Europe Dengue Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 41. Asia-Pacific Dengue Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 42. Asia-Pacific Dengue Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 43. Asia-Pacific Dengue Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 44. Asia-Pacific Dengue Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 45. Asia-Pacific Dengue Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 46. Asia-Pacific Dengue Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 47. South America Dengue Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 48. South America Dengue Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 49. South America Dengue Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 50. South America Dengue Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 51. South America Dengue Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 52. South America Dengue Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 53. Middle East & Africa Dengue Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 54. Middle East & Africa Dengue Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 55. Middle East & Africa Dengue Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 56. Middle East & Africa Dengue Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 57. Middle East & Africa Dengue Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 58. Middle East & Africa Dengue Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 59. Dengue Vaccines Raw Material
Table 60. Key Suppliers of Dengue Vaccines Raw Materials
List of Figures
Figure 1. Dengue Vaccines Picture
Figure 2. Global Dengue Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Dengue Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Dengvaxia
Figure 5. TAK-003
Figure 6. Others
Figure 7. Global Dengue Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Dengue Vaccines Consumption Value Market Share by Application in 2022
Figure 9. Public Sector Picture
Figure 10. Private Sector Picture
Figure 11. Global Dengue Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Dengue Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Dengue Vaccines Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Dengue Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Dengue Vaccines Consumption Value Market Share by Region in 2022
Figure 16. North America Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Dengue Vaccines Revenue Share by Players in 2022
Figure 22. Dengue Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Dengue Vaccines Market Share in 2022
Figure 24. Global Top 6 Players Dengue Vaccines Market Share in 2022
Figure 25. Global Dengue Vaccines Consumption Value Share by Type (2018-2023)
Figure 26. Global Dengue Vaccines Market Share Forecast by Type (2024-2029)
Figure 27. Global Dengue Vaccines Consumption Value Share by Application (2018-2023)
Figure 28. Global Dengue Vaccines Market Share Forecast by Application (2024-2029)
Figure 29. North America Dengue Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Dengue Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Dengue Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Dengue Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Dengue Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Dengue Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 39. France Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Dengue Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Dengue Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Dengue Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 46. China Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 49. India Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Dengue Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Dengue Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Dengue Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Dengue Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Dengue Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Dengue Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Dengue Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 63. Dengue Vaccines Market Drivers
Figure 64. Dengue Vaccines Market Restraints
Figure 65. Dengue Vaccines Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Dengue Vaccines in 2022
Figure 68. Manufacturing Process Analysis of Dengue Vaccines
Figure 69. Dengue Vaccines Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
